<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>50 cases were treated with <z:hpo ids='HP_0002863'>Myelodysplastic Syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) by combined TCM-WM therapy </plain></SENT>
<SENT sid="1" pm="."><plain>They were classified into RA 17 cases, <z:mp ids='MP_0011356'>RAS</z:mp> 6, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> 19, <z:e sem="disease" ids="C1333043" disease_type="Neoplastic Process" abbrv="">CMML 1</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEBT</z:e> 7 </plain></SENT>
<SENT sid="2" pm="."><plain>The patients were divided into two groups, one with RA and <z:mp ids='MP_0011356'>RAS</z:mp> receiving treatment of hemopoietic and immune drugs plus Chinese medicinal herbs, the other with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEBT</z:e> receiving treatment of LD Ara-c and LD Hom chemotherapy plus medicinal herbs </plain></SENT>
<SENT sid="3" pm="."><plain>The effective rates were 47.83% and 62.96% respectively, the total effective rate being 56% </plain></SENT>
<SENT sid="4" pm="."><plain>6 cases (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> 4, RA 1, <z:mp ids='MP_0011356'>RAS</z:mp> 1) were treated with <z:hpo ids='HP_0000001'>all</z:hpo>-trans <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> used as an inducer of differentiation, 2 of them were effective </plain></SENT>
<SENT sid="5" pm="."><plain>11 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> who had transformed into <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> were treated by LD Ara-c and combined TCM-WM chemotherapy, the remission rate was 54.55% and the survival period was 9-27 months after remission </plain></SENT>
<SENT sid="6" pm="."><plain>In some cases low dose chemotherapy resulted in hemocytopenia, bone marrow inhibition, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, mild <z:hpo ids='HP_0002018'>nausea</z:hpo> and <z:hpo ids='HP_0002039'>anorexia</z:hpo> </plain></SENT>
</text></document>